Novo Nordisk lawsuit against Eli Lilly defended by CEO over Wegovy ads
Novo CEO Mike Doustdar says Lilly’s Zepbound ads leave out newer Wegovy data, while Lilly says its comparisons are truthful.
Section
Novo CEO Mike Doustdar says Lilly’s Zepbound ads leave out newer Wegovy data, while Lilly says its comparisons are truthful.
The Kospi is back above its bull-market threshold after July’s selloff, but its durability rests on chip earnings, AI spending and...
Standard Chartered and Jio BlackRock are adding to fund activity at GIFT City, where rules offer a route around India’s outbound-i...
Treasury yields moved lower early Thursday as investors awaited July producer-price data after an in-line consumer inflation readi...
Goldman says Japan can fund more large yen-buying operations, though rate gaps may limit how long intervention supports the curren...
Saudi crude moving through Egypt’s SUMED pipeline has surged, offering a route away from Bab el-Mandeb but adding costs for Asia-b...
Gold posted its best week since January as rate-hike expectations eased, but investors are still facing a volatile, macro-driven t...
Trump said Karoline Leavitt will leave the White House press secretary job by the end of August and serve as an outside adviser.
Trump officials discussed shielding more home-sale gains from tax, but no proposal is official and Congress would have to change t...
Wendy’s shares rose and trading paused for volatility after a report said Trian Fund Management is preparing a take-private propos...
Bob Iger and Josh Kushner have a deal for the Lakers, but NBA approval is still pending and the reported valuation is 25% above 20...
Norges Bank Investment Management posted a nearly $185 billion first-half profit, but CEO Nicolai Tangen said the gains were conce...